Table 1 Characteristics of study subjects (N = 137)
Characteristic | Cases (%) |
|---|---|
Age (years) | |
≤50 | 78 (56.93) |
>50 | 59 (43.07) |
Age at menarche | |
≤12 | 26 (18.98) |
>12 | 111 (81.02) |
Menopausal status | |
Premenopausal | 40 (29.20) |
Postmenopausal | 97 (70.80) |
Age at menopause | |
≤45 | 33 (34.02) |
>45 | 64 (65.98) |
ER status | |
Positive | 81 (59.12) |
Negative | 56 (40.88) |
PR status | |
Positive | 47 (34.31) |
Negative | 90 (65.69) |
Her2 status | |
Positive | 66 (48.18) |
Negative | 71 (51.82) |
Molecular subtypes of breast cancer | |
Luminal A | 46 (33.58) |
Luminal B | 38 (27.74) |
Her2-enriched | 28 (20.44) |
TNBC | 25 (18.25) |
Tumor size | |
≤5 | 55 (40.15) |
>5 | 82 (59.85) |
Lymph node status | |
Positive | 99 (72.26) |
Negative | 38 (27.74) |
Clinical stage | |
I+II | 45(32.85) |
III+IV | 92(67.15) |
Histological grade | |
I+II | 95 (69.34) |
III | 42 (30.66) |